세계의 의료용 방사선 차폐 시장 : 제품별, 용도별, 최종사용자별, 지역별, 기회 및 예측(2018-2032년)

Global medical radiation shielding market is projected to witness a CAGR of 6.35% during the forecast period 2025-2032, growing from USD 1.51 billion in 2024 to USD 2.47 billion in 2032. The global medical radiation shielding market is experiencing rapid growth due to the rising cases of cancer and chronic disease, advancements implementation in technology, safety awareness protocols, and the development of healthcare infrastructure.

The global medical radiation shielding market is growing at a rapid pace and will likely continue to grow with the increase in medical imaging and treatment utilizing radiation, along with greater awareness surrounding the necessity of radiation safety. As healthcare providers acquire new and more advanced imaging modalities (CT scans, PET-CT, and radiation therapy systems), ensuring accurate shielding methods for patients from harmful radiation is an ever-increasing concern. This radiation shielding system will dependably guarantee the safety of patients and medical staff from ionizing radiation. The medical radiation shielding market has also seen an increase in various aspects of medical and occupational safety in delivering imaging/examination services and increasingly complex radiology departments, as well as environmental regulations concerning strict adherence to rational protection standards. The availability of shielding materials (lead, tungsten, and new lead-free materials) is expected to increase as medical healthcare environments continue to scale globally (the vast majority in emerging economies). The development of new shielding solutions is also being driven by developments in technology (mobile imaging and AI-enabled dose monitoring).

Furthermore, to ensure patient safety in February 2023, to reduce unnecessary radiation, and to enhance diagnosis, companies are launching new age technologies like mobile X-rays to ensure the lowest amount of radiation. It is also easy to use, lightweight, and good for intensive care unit (ICU) patients.

Increasing Awareness of Chronic Diseases

The increasing cases of chronic diseases such as cancer, cardiovascular diseases, and neurological diseases will enhance the radiation shielding market. Chronic diseases often require repeated diagnostic imaging studies (X-ray, CT scan, PET scan) for early detection, diagnosis, and ongoing observation. Radiation therapy is also a mainstay of treatment for various malignant conditions, which leads to a further increase in demand for effective shielding in cancer treatment centers. Overall, the medical conditions will increase the incidence and subsequently, the management, of their associated procedures, and these procedures frequently utilize ionizing radiation, which will drive the need for good, effective protection for patients and healthcare workers to safeguard against harmful exposure. These points contribute to an excellent opportunity for market growth.

For instance, in January 2025, the American Cancer Society projected that 2,041,910 new cancer cases and 618,120 cancers deaths would occur in the United States in these years, which increased the demand for radiotherapy imaging.

Increasing Awareness of Radiation Safety Protocols

Increasing awareness of radiation safety protocols for healthcare personnel, patients, and regulators is one of the key parameters driving the global medical radiation shielding market. Many are rightly concerned with the long-term effects of exposure to ionizing radiation and potential health effects such as cancer, cataracts, and genetic damage. This is the basis for the ALARA (As Low As Reasonably Achievable) policy and principle in radiation safety. ALARA is about minimizing any possible unnecessary exposure and trying to have clinically effective procedures. Because of this healthcare organizations are establishing effective shielding practices, i.e. room shielding, personal protective equipment like lead aprons and thyroid shields, mobile shielding equipment, etc., the need for radiation safety training is establishing safety culture and trust towards the healthcare system in many of these areas, it increases demand for medical shielding materials to be able to provide timely access safety measures with dependable, high-performance shielding systems, as expected by the medical community when providing a shielding solution.

Additionally, to protect patients and healthcare workers from radiation exposure in February 2023, Specialist Door Solutions (SDS) has proudly launched their Shieldoor lead-lined, x-ray doors for protecting not just from harmful radiation and x-ray exposure but also protecting against the rugged and demanding environments of hospitals and radiology.

Technology Advancement in Imaging and Therapy

Technological advancements in imaging capacity and radiation therapy have markedly improved imaging diagnostic accuracy and therapeutic precision in modern healthcare. Alongside technological innovation, such as photon-counting CT (PCCT), PET-CT, intensity-modulated radiation therapy (IMRT), proton therapy, and adaptive radiotherapy have unquestionably improved patient outcomes while complicating patient and staff risk exposures through increased radiation levels, multi-angle beam delivery of radiation, and longer procedures. It has led to increasing demand for advanced radiation shielding solutions, including shielding via thick concrete walls, neutron-absorbing walls for proton therapy, lightweight composite materials, modular panels, smart shielding systems, and other devices. Further complicating these imaging and technology solutions, healthcare facilities are required to upgrade shielding to not only meet safety but also regulatory needs.

For instance, in May 2024, as part of the Chinese Academy of Sciences, Hefei Institutes of Physical Science created a new type of composite material for shielding degradation due to neutron and gamma radiation. The researchers used micron plate Sm2O3, a rare-earth-based filler, to improve the boron-based polyethylene composite.

Government Initiatives Act as a Catalyst

Government efforts are supporting growth in the field of medical radiation shielding through regulatory authorities such as the US Nuclear Regulatory Commission (NRC), the Food and Drug Administration (FDA), and in India, the Atomic Energy Regulatory Board (AERB), developing strict regulations on radiation safety in health care. Similar to government initiatives promoting business growth, many governments provide funding for projects to improve the healthcare infrastructure, to guarantee that new healthcare facilities invest in medical radiation shielding technology. Government programs enhance knowledge and training regarding radiation safety, foster investment in safer options, and create safety protocols for new medical technologies, which inevitably leads to a demand for advanced radiation shielding. Additionally, the rising shift towards lead-free options is influencing market dynamics and creating opportunities for producers and suppliers to create more sustainable and safer shielding materials.

Additionally, the government is also taking care of healthcare professionals by reducing the burden of workload by launching and updating radiation safety rules. For instance, in January 2023, the FDA announced a final rule that greatly reduces record-keeping requirements for X-ray medical devices, among others. According to the agency, this action will greatly reduce the administrative burdens for it and the medical device industry and will try to reduce unnecessary and duplicative regulatory requirements.

Diagnostic Centers Hold Largest Market Shares

Diagnostic shielding takes the lead in medical radiation shielding due to the massive number of diagnostic imaging that are done all over the world, which is more than radiation therapy. Diagnostic imaging involves millions of different procedures in the world of healthcare, and that encompasses multiple modalities; X-rays, CT scans, mammograms, and fluoroscopy all taking place at different healthcare systems from large hospitals to small clinics. This creates a very large and steady demand for shielding for walls, doors, windows, and personal protective equipment (PPE). With the growing focus on routine screenings and early detection of diseases, this volume is only growing.

Additionally, the Government also supports this market by opening imaging centers. For instance, in October 2023, the Health and Social Care secretary announced that they are targeting to open 160 diagnostic centers from the previous year 2024, but their original target is 2025 to speed up access to potentially lifesaving tests and checks.

North America Dominates the Radiation Shielding Market

North America leads the market for medical radiation shielding because of its modular infrastructure and healthcare resources, as there are large numbers of hospitals and diagnostic facilities available, which encompass many more options for imaging and radiation therapy. Not only does North America have availability in terms of healthcare resources, but it also has structural guidelines regulating radiation safety; this suggests concern for the strength of radiation safety because of high levels of oversight from regulatory entities like the US Nuclear Radiation Commission (NRC) and the Food and Drugs Administration (FDA). There have been significant levels of safety and clinical indications for medical radiation use with chronic diseases and illnesses like cancer that are associated with high numbers of radiation diagnostic and treatment uses. North America is consistently engaged in and applies technological innovations in medical imaging and radiation therapy, enabling healthcare facilities to invest in advanced and tailored solutions for their medical shielding.

To support this region in January 2024, Canada SDI announced that they will collaborate with Artemis Shielding for an alternative solution to lead-based radiation shielding for customers in Canada. This collaboration also helps Artemis to generate revenue and set the stage for innovation because this region is leading to chronic diseases and the opening of diagnostic centers.

Impact of U.S. Tariffs on Global Medical Radiation Shielding Market

The impact of U.S. tariffs on the medical radiation shielding market due to:

Increased Costs: Tariffs raise the price of raw materials and finished goods being imported, creating higher prices for hospitals and patients.

Supply Chain Changes: Manufacturers may change the sources or manufacturing process to avoid tariffs, causing delays or added costs.

Decreased Innovation: Increased costs and uncertainty might reduce incentives for manufacturers to invest in research and inventions into future shielding technologies.

Changes to Competition: Domestic U.S. manufacturers may gain advantages, while U.S. suppliers could face countervailing tariffs.

Concerns about Healthcare Affordability: Increased costs of equipment will add strain on healthcare budgets and may impact access to needed services.

Key Players Landscape and Outlook

Key players are differentiating themselves through ongoing product innovation, utilizing lead-free or less toxic materials, and through mergers and acquisitions that enhance their portfolio and global presence. The primary competitive advantages for these firms lie in their technological expertise, commitment to safety regulations, and extensive distribution networks that cater to hospitals and diagnostic facilities worldwide. Companies are going toward partnerships and collaboration to generate revenue and maintain market trends.

For instance, in February 2025, BIOTRONIK announced it is partnering with radiation protection technology company Egg Medical, Inc., to enhance radiation protection for healthcare professionals as well as their patients. The main reason is to provide excellence in life.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of the U.S. Tariffs

4. Executive Summary

5. Global Medical Radiation Shielding Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. MRI Shielding Products
    • 5.2.1.2. Lead-lined Walls/Doors/Windows
    • 5.2.1.3. Lead Aprons/Vests
    • 5.2.1.4. Lead Curtains
    • 5.2.1.5. Lead Bricks
    • 5.2.1.6. Lead Sheets
    • 5.2.1.7. Radiation Shielding Barriers/Booths
    • 5.2.1.8. Others Radiation Shielding Products
  • 5.2.2. By Application
    • 5.2.2.1. Radiation Therapy Shielding
      • 5.2.2.1.1. Linear Accelerators
      • 5.2.2.1.2. Multimodality Imaging
      • 5.2.2.1.3. Cyclotrons
      • 5.2.2.1.4. Brachytherapy
      • 5.2.2.1.5. Proton Therapy
    • 5.2.2.2. Diagnostic Shielding
      • 5.2.2.2.1. X-ray
      • 5.2.2.2.2. MRI
      • 5.2.2.2.3. CT scanners
      • 5.2.2.2.4. Nuclear Imaging
      • 5.2.2.2.5. Other Applications
  • 5.2.3. By End-user
    • 5.2.3.1. Hospitals and Clinics
    • 5.2.3.2. Diagnostic Centers
    • 5.2.3.3. Ambulatory Surgery Centers
  • 5.2.4. By Region
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia-Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East and Africa
  • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By End-user
  • 5.3.4. By Region

6. North America Medical Radiation Shielding Market Outlook, 2018-2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Product
    • 6.2.1.1. MRI Shielding Products
    • 6.2.1.2. Lead-lined Walls/Doors/Windows
    • 6.2.1.3. Lead Aprons/Vests
    • 6.2.1.4. Lead Curtains
    • 6.2.1.5. Lead Bricks
    • 6.2.1.6. Lead Sheets
    • 6.2.1.7. Radiation Shielding Barriers/Booths
    • 6.2.1.8. Others Radiation Shielding Products
  • 6.2.2. By Application
    • 6.2.2.1. Radiation Therapy Shielding
      • 6.2.2.1.1. Linear Accelerators
      • 6.2.2.1.2. Multimodality Imaging
      • 6.2.2.1.3. Cyclotrons
      • 6.2.2.1.4. Brachytherapy
      • 6.2.2.1.5. Proton Therapy
    • 6.2.2.2. Diagnostic Shielding
      • 6.2.2.2.1. X-ray
      • 6.2.2.2.2. MRI
      • 6.2.2.2.3. CT scanners
      • 6.2.2.2.4. Nuclear Imaging
    • 6.2.2.3. Other Applications
  • 6.2.3. By End-user
    • 6.2.3.1. Hospitals and Clinics
    • 6.2.3.2. Diagnostic Centers
    • 6.2.3.3. Ambulatory Surgery Centers
  • 6.2.4. By Country Share
    • 6.2.4.1. United States
    • 6.2.4.2. Canada
    • 6.2.4.3. Mexico
• 6.3. Country Market Assessment
  • 6.3.1. United States Medical Radiation Shielding Market Outlook, 2018-2032F*
    • 6.3.1.1. Market Size Analysis & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share Analysis & Forecast
      • 6.3.1.2.1. By Product
        • 6.3.1.2.1.1. MRI Shielding Products
        • 6.3.1.2.1.2. Lead-lined Walls/Doors/Windows
        • 6.3.1.2.1.3. Lead Aprons/Vests
        • 6.3.1.2.1.4. Lead Curtains
        • 6.3.1.2.1.5. Lead Bricks
        • 6.3.1.2.1.6. Lead Sheets
        • 6.3.1.2.1.7. Radiation Shielding Barriers/Booths
        • 6.3.1.2.1.8. Others Radiation Shielding Products
      • 6.3.1.2.2. By Application
        • 6.3.1.2.2.1. Radiation Therapy Shielding
        • 6.3.1.2.2.1.1. Linear Accelerators
        • 6.3.1.2.2.1.2. Multimodality Imaging
        • 6.3.1.2.2.1.3. Cyclotrons
        • 6.3.1.2.2.1.4. Brachytherapy
        • 6.3.1.2.2.1.5. Proton Therapy
        • 6.3.1.2.2.2. Diagnostic Shielding
        • 6.3.1.2.2.2.1. X-ray
        • 6.3.1.2.2.2.2. MRI
        • 6.3.1.2.2.2.3. CT scanners
        • 6.3.1.2.2.2.4. Nuclear Imaging
        • 6.3.1.2.2.3. Other Applications
      • 6.3.1.2.3. By End-user
        • 6.3.1.2.3.1. Hospitals and Clinics
        • 6.3.1.2.3.2. Diagnostic Centers
        • 6.3.1.2.3.3. Ambulatory Surgery Centers
  • 6.3.2. Canada
  • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Medical Radiation Shielding Market Outlook, 2018-2032F

• 7.1. Germany
• 7.2. France
• 7.3. Italy
• 7.4. United Kingdom
• 7.5. Russia
• 7.6. Netherlands
• 7.7. Spain
• 7.8. Turkey
• 7.9. Poland

8. Asia-Pacific Medical Radiation Shielding Market Outlook, 2018-2032F

• 8.1. India
• 8.2. China
• 8.3. Japan
• 8.4. Australia
• 8.5. Vietnam
• 8.6. South Korea
• 8.7. Indonesia
• 8.8. Philippines

9. South America Medical Radiation Shielding Market Outlook, 2018-2032F

• 9.1. Brazil
• 9.2. Argentina

10. Middle East and Africa Medical Radiation Shielding Market Outlook, 2018-2032F

• 10.1. Saudi Arabia
• 10.2. UAE
• 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

• 17.1. Market Drivers
• 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Framework

• 19.1. Regulatory Approvals
• 19.2. Innovations

20. Patent Landscape

21. Case Studies

22. Competitive Landscape

• 22.1. Competition Matrix of Top 5 Market Leaders
• 22.2. SWOT Analysis for Top 5 Players
• 22.3. Key Players Landscape for Top 10 Market Players
  • 22.3.1. Marswell Group of Companies (MarShield)
    • 22.3.1.1. Company Details
    • 22.3.1.2. Key Management Personnel
    • 22.3.1.3. Products and Services
    • 22.3.1.4. Financials (As Reported)
    • 22.3.1.5. Key Market Focus and Geographical Presence
    • 22.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 22.3.2. Gaven Industries Inc.
  • 22.3.3. ETS-Lindgren Inc.
  • 22.3.4. Ray-Bar Engineering Corporation
  • 22.3.5. Amray Group
  • 22.3.6. A&L Shielding Inc.
  • 22.3.7. Burlington Medical LLC
  • 22.3.8. Nuclear Shields B.V.
  • 22.3.9. Veritas Medical Solutions Inc.
  • 22.3.10. MAVIG GmbH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

23. Strategic Recommendations

24. About Us and Disclaimer